Prospective longitudinal bio-specimen collection in patients with early breast cancer patients who receive pre-operative systemic therapy, post-operative adjuvant systemic therapy, and metastatic breast cancer

Clinical Trial Details

The purpose of this study is to collect information about patients with breast cancer, as well as studying their blood and/or other tissue in the laboratory to better study the cause and treatment of breast cancer.

Through this study, investigators hope to find new markers that will help prevent, detect, and manage patients with breast cancer. By studying the clinical course of patients with cancers of the breast and by performing additional laboratory studies, we hope to learn more about what causes these cancers and help identify new treatments for patients.

Participants blood and tissue will be collected during their standard of care appointments.

Key Eligibility:

Open to persons at least 18 years old who have newly diagnosed invasive breast cancer OR metastatic disease
Must be willing to undergo biopsy and/or blood collection for research

Detailed eligibility will be reviewed when you contact the study team.

Return to List

Study contact by location

Upper East Side - Manhattan

Contact(s)

June Greenberg, RN
(212) 746-2651
jdg2002@med.cornell.edu

Primary Investigator(s)

Eleni Andreopoulou, MD

Protocol ID(s)

Weill Cornell Medicine IRB #:

1603017108

Status

Open to Enrollment

Age Group

Adult

Disease

Breast Cancer